Protease inhibitors (PI) pose a challenge post‐transplant due to significant drug interactions with calcineurin inhibitors, prompting many clinicians to convert patients to non‐interacting regimens prior to transplant. The purpose of… Click to show full abstract
Protease inhibitors (PI) pose a challenge post‐transplant due to significant drug interactions with calcineurin inhibitors, prompting many clinicians to convert patients to non‐interacting regimens prior to transplant. The purpose of this study was to examine the impact of PI‐based regimens on graft outcomes in HIV‐infected renal transplant recipients.
Keywords:
outcomes hiv;
impact antiretroviral;
transplant;
renal transplant;
antiretroviral regimen;
hiv infected
Journal Title: Transplant Infectious Disease
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transplant Infectious Disease
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!